Societal preferences for adjuvant melanoma health states: UK and Australia
Abstract Background No studies have measured preference-based utility weights for specific toxicities and outcomes associated with approved and investigational adjuvant treatments for patients with resected high-risk melanoma. Methods A cross-sectional study was conducted in the United Kingdom and A...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Cancer |
Online Access: | http://link.springer.com/article/10.1186/s12885-017-3673-y |